Chylothorax, a known complication of surgery for Congenital Diaphragmatic hernia, can sometimes be resistant to treat. Octeriotide (Somatostatin analogue) can be useful in this situation. However, the dose and schedule of Octeriotide therapy in neonates is not well established. We report two cases of resistant chylothorax following surgery for congenital diaphragmatic hernia which were successfully managed by using an escalating infusion of octeriotide. The literature on the subject is also reviewed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743138PMC
http://dx.doi.org/10.4103/2249-4847.96767DOI Listing

Publication Analysis

Top Keywords

congenital diaphragmatic
12
diaphragmatic hernia
12
report cases
8
surgery congenital
8
octeriotide
4
octeriotide management
4
management neonatal
4
neonatal chylothorax
4
chylothorax secondary
4
secondary repair
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!